Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
US-12128212-B2 · Oct 29, 2024 · US
US9968742B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9968742-B2 |
| Application number | US-89710607-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2007 |
| Priority date | Aug 29, 2007 |
| Publication date | May 15, 2018 |
| Grant date | May 15, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments of the invention provide a dual insertion set for supplying a fluid to a body of a patient and for monitoring a body characteristic of the patient. Typical embodiments of the invention include a base, an infusion portion coupled to a first piercing member and a sensor portion coupled to a second piercing member. The infusion portion includes a cannula coupled to the first piercing member for supplying the fluid to a placement site. The sensor portion includes a sensor coupled to and extending from the base having at least one sensor electrode formed on a substrate and is coupled to the second piercing member in a manner that allows the sensor to be inserted at the placement site. The base is arranged to secure the dual insertion set to skin of the patient. Typically the first and second piercing members are arranged such that when the first and second piercing members are operatively coupled to the base, they are disposed in a spatial orientation designed to inhibit sensor interference that may be caused by compounds present in fluids infused through the cannula.
Opening claim text (preview).
The invention claimed is: 1. A method for inhibiting interference of an electrochemical glucose sensor that monitors glucose levels in a patient, wherein the interference is caused by a phenolic preservative present in an insulin infusate infused by an apparatus for supplying a fluid to a body of the patient, the method comprising supplying the fluid to the body of the patient using the apparatus comprising: a base adapted to secure the apparatus to skin of the patient; a first piercing member coupled to and extending from the base, wherein the first piercing member comprises at least one cannula for infusing the fluid to an infusion site, a second piercing member coupled to and extending from the base and including the electrochemical sensor having a sensor electrode for determining the glucose levels of the patient at a sensor placement site, infusion set tubing adapted to connect to the at least one cannula; wherein: the first and second piercing members are disposed on a hub that can operatively engage and disengage from the base; the first and second piercing members are coupled to the base in an orientation such that when the first and second piercing members are inserted into the patient, a first perforation channel made by the first piercing member is not in operable contact with a second perforation channel made by the second piercing member such that the fluid infused to the infusion site cannot flow through the first perforation channel or the second perforation channel to the sensor; and the first and second piercing members are coupled to the base in the orientation such that when the first and second piercing members are inserted into the patient, the sensor and the at least one cannula are separated by at least seven millimeters of tissue; so that the interference is inhibited. 2. The method of claim 1 , wherein the sensor comprises a plurality of layers including: a glucose oxidase layer that detectably alters an electrical current at the electrode in a presence of glucose; and an analyte modulating layer that modulates diffusion of glucose therethrough. 3. The method of claim 1 , wherein the first and second piercing members are inserted into separate in vivo environments. 4. The method of claim 1 , further comprising a medication infusion pump adapted to connect to the infusion set tubing. 5. A method for inhibiting interference of an electrochemical sensor that monitors a body characteristic of a patient, wherein the interference is caused by an interferant present in an infusate infused by an apparatus for supplying a fluid to a body of the patient, the method comprising supplying the fluid to the body of the patient using the apparatus comprising: a base adapted to secure the apparatus to skin of the patient; a first piercing member coupled to and extending from the base, wherein the first piercing member comprises at least one cannula for infusing the fluid to an infusion site, a second piercing member coupled to and extending from the base and including the electrochemical sensor having a sensor electrode for determining the body characteristic of the patient at a sensor placement site, infusion set tubing adapted to connect to the at least one cannula; wherein: the first and second piercing members are disposed on a hub that can operatively engage and disengage from the base; the first and second piercing members are coupled to the base in an orientation such that when the first and second piercing members are inserted into the patient, a first perforation channel made by the first piercing member is not in operable contact with a second perforation channel made by the second piercing member such that the fluid infused to the infusion site cannot flow through the first perforation channel or the second perforation channel to the sensor; the first and second piercing members are coupled to the base in the orientation such that when the first and second piercing members are inserted into the patient, the sensor and the at least one cannula are separated by at least seven millimeters of tissue; and the first and second piercing members are coupled to the base in the orientation so that when the at least one cannula and the sensor are disposed in the patient, the at least one cannula and the sensor function to anchor the apparatus to the skin of the patient; so that the interference is inhibited.
with needle insertion means · CPC title
invasive, e.g. introduced into the body by a catheter · CPC title
for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title
for measuring glucose, e.g. by tissue impedance measurement · CPC title
electrical or electronic {(A61M5/16804, A61M5/16831 take precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.